Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
Published Online: 2020-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Abigail Evans•Andrew Dodson•Anthony Skene•Chris Holcombe•Cliona Kirwan•Elizabeth Mallon•Ian Smith•James Morden•Jane Banerji•John Robertson•Judith M Bliss•Kally Sidhu•Kieran Horgan•Lucy Kilburn•Maggie Cheang•Maggie Wilcox•Mark Sibbering•Mitch Dowsett•Raghavan Vidya
